Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients

被引:20
作者
Schwenk, A [1 ]
Kremer, G [1 ]
Cornely, O [1 ]
Diehl, V [1 ]
Fätkenheuer, G [1 ]
Salzberger, B [1 ]
机构
[1] Univ Cologne, Dept Internal Med, Cologne, Germany
关键词
acquired immunodeficiency syndrome; anti-HIV agents; body weight; cachexia; HIV-protease inhibitors; malnutrition wasting syndrome; weight loss;
D O I
10.1016/S0899-9007(99)00083-0
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Effective reduction of HIV replication by protease inhibitor (PI) treatment was expected to reverse some of the weight loss associated with HIV infection. Body weight changes in undernourished HIV-infected patients starting PI treatment were compared to its virologic and immunologic effects. This was designed as a retrospective study using prospectively collected weight data; the setting was the HN outpatient department of a university hospital. Among 223 consecutive HIV-positive patients starting treatment with PI February 1996 to September 1997, 63 undernourished patients were evaluable. The main outcome measures were weight trend, calculated by Linear regression of a patient's weight versus time, and its change from a 4-14-wk baseline period to the first 14 wk, and 28 wk, after treatment. In our results, weight trend remained unchanged (baseline, + 0.4 +/- 4.0 kg/100 d; 14 wk, + 0.7 +/- 4.1 kg/100 d, and 28 wk, + 1.0 +/- 3.4 kg/100 d, n.s.). Reduction of viremia and increase in CD4 cell count were unrelated to weight trends. Treatment with PI did not result in an improved weight trend. Altered body composition with PI treatment, as observed in other studies, does not seem to result in body weight changes. Drug side effects may have counteracted any positive effects. The metabolic and nutritional impact of effective antiviral treatment merits further study. (C) Elsevier Science Inc. 1999.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 30 条
[1]  
[Anonymous], 1998, MMWR Recomm Rep, V47, P1
[2]  
CABONNEL F, 1998, AIDS, V12, P1777
[3]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[4]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[5]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883
[6]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P43
[7]   A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].
DANNER, SA ;
CARR, A ;
LEONARD, JM ;
LEHMAN, LM ;
GUDIOL, F ;
GONZALES, J ;
RAVENTOS, A ;
RUBIO, R ;
BOUZA, E ;
PINTADO, V ;
AGUADO, AG ;
DELOMAS, JG ;
DELGADO, R ;
BORLEFFS, JCC ;
HSU, A ;
VALDES, JM ;
BOUCHER, CAB ;
COOPER, DA ;
GIMENO, C ;
CLOTET, B ;
TOR, J ;
FERRER, E ;
MARTINEZ, PL ;
MORENO, S ;
ZANCADA, G ;
ALCAMI, J ;
NORIEGA, AR ;
PULIDO, F ;
GLASSMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533
[8]   Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy [J].
Foudraine, NA ;
Weverling, GJ ;
van Gool, T ;
Roos, MTL ;
de Wolf, F ;
Koopmans, PP ;
van den Broek, PJ ;
Meenhorst, PL ;
van Leeuwen, R ;
Lange, JMA ;
Reiss, P .
AIDS, 1998, 12 (01) :35-41
[9]   WASTING IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
GRUNFELD, C ;
KOTLER, DP .
SEMINARS IN LIVER DISEASE, 1992, 12 (02) :175-187
[10]   Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].
Gulick, RM ;
Mellors, JW ;
Havlir, D ;
Eron, JJ ;
Gonzalez, C ;
McMahon, D ;
Richman, DD ;
Valentine, FT ;
Jonas, L ;
Meibohm, A ;
Emini, EA ;
Chodakewitz, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739